Gene · 7994
Papers1,720
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,720
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ERα status of invasive ductal breast carcinoma as a result of regulatory interactions between lysine deacetylases KAT6A and KAT6B. | Sci Rep | 2024 | 39505971 | PubTator, text mining | PubMed |
| Discovery and Characterization of BAY-184: A New Potent and Selective Acylsulfonamide-Benzofuran In Vivo-Active KAT6AB Inhibitor. | J Med Chem | 2024 | 39450890 | PubTator, text mining | PubMed |
| Histone-modifying enzymes and gastric cancer: Search for potential biomarkers and therapeutic targets based on Mendelian randomization. | Heliyon | 2024 | 39403517 | PubTator, text mining | PubMed |
| Expanding the molecular landscape of childhood apraxia of speech: evidence from a single-center experience. | Front Neurosci | 2024 | 39381681 | PubTator, text mining | PubMed |
| The small inhibitor WM-1119 effectively targets KAT6A-rearranged AML, but not KMT2A-rearranged AML, despite shared KAT6 genetic dependency. | J Hematol Oncol | 2024 | 39380002 | PubTator, text mining | PubMed |
| Identification of triazolyl KAT6 inhibitors via a templated fragment approach. | Bioorg Med Chem Lett | 2024 | 39236793 | PubTator, text mining | PubMed |
| Circ_0005397 inhibits ferroptosis of pancreatic cancer cells by up-regulating PCBP2 through KAT6A/H3K9Ac. | FASEB J | 2024 | 39235355 | PubTator, text mining | PubMed |
| KAT6A/YAP/TEAD4 pathway modulates osteoclastogenesis by regulating the RANKL/OPG ratio on the compression side during orthodontic tooth movement. | Prog Orthod | 2024 | 39129034 | PubTator, text mining | PubMed |
| Functional characterization of BbEaf6 in Beauveria bassiana: Implications for fungal virulence and stress response. | Virulence | 2024 | 39082211 | PubTator, text mining | PubMed |
| Mechanism and application of feedback loops formed by mechanotransduction and histone modifications. | Genes Dis | 2024 | 39071110 | PubTator, text mining | PubMed |
| KAT6A Condensates Impair PARP1 Trapping of PARP Inhibitors in Ovarian Cancer. | Adv Sci (Weinh) | 2024 | 38973255 | PubTator, text mining | PubMed |
| Epigenetic modulators provide a path to understanding disease and therapeutic opportunity. | Genes Dev | 2024 | 38914477 | PubTator, text mining | PubMed |
| Whole genome sequencing of HER2-positive metastatic extramammary Paget's disease: a case report. | Orphanet J Rare Dis | 2024 | 38831459 | PubTator, text mining | PubMed |
| Inhibition of lysine acetyltransferase KAT6 in ER+HER2- metastatic breast cancer: a phase 1 trial. | Nat Med | 2024 | 38824244 | PubTator, text mining | PubMed |
| Diagnosis of Arboleda-Tham syndrome by whole-exome sequencing in an Asian girl with severe developmental delay. | Mol Genet Genomic Med | 2024 | 38773911 | PubTator, text mining | PubMed |
| KAT6A deficiency impairs cognitive functions through suppressing RSPO2/Wnt signaling in hippocampal CA3. | Sci Adv | 2024 | 38758792 | PubTator, text mining | PubMed |
| Neuropsychological profile associated with KAT6A syndrome: Emergent genotype-phenotype trends. | Orphanet J Rare Dis | 2024 | 38741077 | PubTator, text mining | PubMed |
| Broadening the ocular phenotypic spectrum of ultra-rare BRPF1 variants: report of two cases. | Ophthalmic Genet | 2024 | 38590032 | PubTator, text mining | PubMed |
| Protein crotonylation: Basic research and clinical diseases. | Biochem Biophys Rep | 2024 | 38586826 | PubTator, text mining | PubMed |
| RAD51C and MYST3 Mutations in a Case of Desmoid-Type Fibromatosis With No Mutation in CTNNB1 or APC. | Cureus | 2024 | 38571839 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7994/papers?page=6